1. ^{{Cite web|url =https://www.gmdnagency.com|title =Global Medical Device Network|date =|access-date =|website =|publisher =|deadurl =yes|archiveurl =https://web.archive.org/web/20140815063424/https://www.gmdnagency.com/|archivedate =2014-08-15|df =}}
2. ^{{Cite journal|url = |title = The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review|last = Hanai H.|date = January 2011|journal = Clinical & Experimental Immunology|doi = |pmid = |access-date = |volume = 163 | issue = 1 |pages = 50–58|display-authors=etal}}
3. ^{{Cite journal|url = |title = Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation|last = Nikolaus S., Schreiber S.|date = April 1998|journal = Gut|doi = 10.1136/gut.42.4.470|volume = 42|pages = 470–476|display-authors=etal|pmc = 1727082}}
4. ^{{Cite journal|url = |title = Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis.|last = Muratov V.|date = 2008|journal = Journal of Gastroenterology|doi = |pmid = |access-date = |issue = 43|pages = 277–282|display-authors=etal}}
5. ^{{Cite web|url = https://www.ecco-ibd.eu/index.php/publications/congress-abstract-s/abstracts-2015/item/p511-efficacy-and-safety-of-granulocytemonocyte-adsorptive-apheresis-in-steroid-dependent-active-ulcerative-colitis-with-insufficient-response-or-intolerance-to-immunosuppressants-andor-biological-therapies-the-art-trial-results-at-24-and-48-weeks.html?highlight=YToxOntpOjA7czo5OiJhZGFjb2x1bW4iO30|title = P511 Efficacy and safety of granulocyte/monocyte adsorptive apheresis in steroid-dependent Active Ulcerative Colitis with insufficient response or intolerance to immunosuppressants and/or biological therapies (the ART trial): Results at 24 and 48 weeks|date = 2015|access-date = |website = ecco-ibd.eu|publisher = The European Crohn's and Colitis Organisation (ECCO)|last = Dignass A.|display-authors=etal}}